Mendelian Randomization of Dyslipidemia on Cognitive Impairment Among Older Americans

Background: Altered lipid metabolism may be a risk factor for dementia, and blood cholesterol level has a strong genetic component. We tested the hypothesis that dyslipidemia (either low levels of high-density lipoprotein cholesterol (HDL-C) or high total cholesterol) is associated with cognitive st...

Full description

Bibliographic Details
Main Authors: Mingzhou Fu, Kelly M. Bakulski, Cesar Higgins, Erin B. Ware
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-06-01
Series:Frontiers in Neurology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fneur.2021.660212/full
_version_ 1818667909005705216
author Mingzhou Fu
Kelly M. Bakulski
Cesar Higgins
Erin B. Ware
Erin B. Ware
author_facet Mingzhou Fu
Kelly M. Bakulski
Cesar Higgins
Erin B. Ware
Erin B. Ware
author_sort Mingzhou Fu
collection DOAJ
description Background: Altered lipid metabolism may be a risk factor for dementia, and blood cholesterol level has a strong genetic component. We tested the hypothesis that dyslipidemia (either low levels of high-density lipoprotein cholesterol (HDL-C) or high total cholesterol) is associated with cognitive status and domains, and assessed causality using genetic predisposition to dyslipidemia as an instrumental variable.Methods: Using data from European and African genetic ancestry participants in the Health and Retirement Study, we selected observations at the first non-missing biomarker assessment (waves 2006–2012). Cognition domains were assessed using episodic memory, mental status, and vocabulary tests. Overall cognitive status was categorized in three levels (normal, cognitive impairment non-dementia, dementia). Based on 2018 clinical guidelines, we compared low HDL-C or high total cholesterol to normal levels. Polygenic scores for dyslipidemia were used as instrumental variables in a Mendelian randomization framework. Multivariable logistic regressions and Wald-type ratio estimators were used to examine associations.Results: Among European ancestry participants (n = 8,781), at risk HDL-C levels were associated with higher odds of cognitive impairment (OR = 1.20, 95% CI: 1.03, 1.40) and worse episodic memory, specifically. Using cumulative genetic risk for HDL-C levels as a valid instrumental variable, a significant causal estimate was observed between at risk low HDL-C levels and higher odds of dementia (OR = 2.15, 95% CI: 1.16, 3.99). No significant associations were observed between total cholesterol levels and cognitive status. No significant associations were observed in the African ancestry sample (n = 2,101).Conclusion: Our study demonstrates low blood HDL-C is a potential causal risk factor for impaired cognition during aging in non-Hispanic whites of European ancestry. Dyslipidemia can be modified by changing diets, health behaviors, and therapeutic strategies, which can improve cognitive aging. Studies on low density lipoprotein cholesterol, the timing of cholesterol effects on cognition, and larger studies in non-European ancestries are needed.
first_indexed 2024-12-17T06:27:54Z
format Article
id doaj.art-10159549f3724f8a890f29939a48105b
institution Directory Open Access Journal
issn 1664-2295
language English
last_indexed 2024-12-17T06:27:54Z
publishDate 2021-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Neurology
spelling doaj.art-10159549f3724f8a890f29939a48105b2022-12-21T22:00:15ZengFrontiers Media S.A.Frontiers in Neurology1664-22952021-06-011210.3389/fneur.2021.660212660212Mendelian Randomization of Dyslipidemia on Cognitive Impairment Among Older AmericansMingzhou Fu0Kelly M. Bakulski1Cesar Higgins2Erin B. Ware3Erin B. Ware4Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, United StatesDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, United StatesDepartment of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, United StatesSurvey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, United StatesPopulation Studies Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, United StatesBackground: Altered lipid metabolism may be a risk factor for dementia, and blood cholesterol level has a strong genetic component. We tested the hypothesis that dyslipidemia (either low levels of high-density lipoprotein cholesterol (HDL-C) or high total cholesterol) is associated with cognitive status and domains, and assessed causality using genetic predisposition to dyslipidemia as an instrumental variable.Methods: Using data from European and African genetic ancestry participants in the Health and Retirement Study, we selected observations at the first non-missing biomarker assessment (waves 2006–2012). Cognition domains were assessed using episodic memory, mental status, and vocabulary tests. Overall cognitive status was categorized in three levels (normal, cognitive impairment non-dementia, dementia). Based on 2018 clinical guidelines, we compared low HDL-C or high total cholesterol to normal levels. Polygenic scores for dyslipidemia were used as instrumental variables in a Mendelian randomization framework. Multivariable logistic regressions and Wald-type ratio estimators were used to examine associations.Results: Among European ancestry participants (n = 8,781), at risk HDL-C levels were associated with higher odds of cognitive impairment (OR = 1.20, 95% CI: 1.03, 1.40) and worse episodic memory, specifically. Using cumulative genetic risk for HDL-C levels as a valid instrumental variable, a significant causal estimate was observed between at risk low HDL-C levels and higher odds of dementia (OR = 2.15, 95% CI: 1.16, 3.99). No significant associations were observed between total cholesterol levels and cognitive status. No significant associations were observed in the African ancestry sample (n = 2,101).Conclusion: Our study demonstrates low blood HDL-C is a potential causal risk factor for impaired cognition during aging in non-Hispanic whites of European ancestry. Dyslipidemia can be modified by changing diets, health behaviors, and therapeutic strategies, which can improve cognitive aging. Studies on low density lipoprotein cholesterol, the timing of cholesterol effects on cognition, and larger studies in non-European ancestries are needed.https://www.frontiersin.org/articles/10.3389/fneur.2021.660212/fullblood cholesterolpolygenic scoredementiaMendelian randomizationcognitive domain
spellingShingle Mingzhou Fu
Kelly M. Bakulski
Cesar Higgins
Erin B. Ware
Erin B. Ware
Mendelian Randomization of Dyslipidemia on Cognitive Impairment Among Older Americans
Frontiers in Neurology
blood cholesterol
polygenic score
dementia
Mendelian randomization
cognitive domain
title Mendelian Randomization of Dyslipidemia on Cognitive Impairment Among Older Americans
title_full Mendelian Randomization of Dyslipidemia on Cognitive Impairment Among Older Americans
title_fullStr Mendelian Randomization of Dyslipidemia on Cognitive Impairment Among Older Americans
title_full_unstemmed Mendelian Randomization of Dyslipidemia on Cognitive Impairment Among Older Americans
title_short Mendelian Randomization of Dyslipidemia on Cognitive Impairment Among Older Americans
title_sort mendelian randomization of dyslipidemia on cognitive impairment among older americans
topic blood cholesterol
polygenic score
dementia
Mendelian randomization
cognitive domain
url https://www.frontiersin.org/articles/10.3389/fneur.2021.660212/full
work_keys_str_mv AT mingzhoufu mendelianrandomizationofdyslipidemiaoncognitiveimpairmentamongolderamericans
AT kellymbakulski mendelianrandomizationofdyslipidemiaoncognitiveimpairmentamongolderamericans
AT cesarhiggins mendelianrandomizationofdyslipidemiaoncognitiveimpairmentamongolderamericans
AT erinbware mendelianrandomizationofdyslipidemiaoncognitiveimpairmentamongolderamericans
AT erinbware mendelianrandomizationofdyslipidemiaoncognitiveimpairmentamongolderamericans